The global direct fed microbial market was valued at $980 million in 2018, and is expected to reach $1,772million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Microbes are defined as microscopic living organisms which occur in nature as single celled organisms or colony of cells. Some microbes are harmful to human and animal health, whereas as some are highly beneficial for both humans and animals. Therefore, microbes which are supplemented orally to produce benefits in animals are called as direct-fed microbes. Furthermore, this use of microbes as feed supplement exhibits positive impact on the immune response, overall health, and performance of livestock. In addition, some of the direct fed microbial products available in the direct fed microbial market contain specifically selected strains of bacteria,which have the abilities to produce high levels of beneficial enzymes such as alpha amylase, cellulase, and protease. Furthermore, these products are used in various types of animals such as swine, poultry, ruminants, and aquatic animals.
Major factors driving the market growth include increase indemand for meat & milk consumption and rise inprofitability at same cost. Surge in human population and increase in demand for proteinous diet boost the market growth of direct-fed microbial. For instance, human population is increasing at a rate of 1.1% annually. This growth in the population is expected to increase the consumption of animal products such as meat and milk. For example, the consumption of meat has tripled over the last four decades. Furthermore, in the developed countries such as the U.S., the UK, and Germany, the consumption of meat per personis fairly high. Thus, these factors boost the direct fed microbial market growth. 8In addition, probiotics aids nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increase the profitability of the animal producers. However, stringent regulations set regarding the vigorous usage of these microorganisms in animal diet and increase incost of production are the major factors hampering the market growth. On the contrary, ban on the usage of antibiotics in animal diet in developed nations such the U.S., Germany, and the UK and rise in animal health concerns are some of the major factors expected to providelucrative opportunities for direct fed microbial market expansion in the near future.
Direct Fed Microbial Market Segmentation
The direct fed microbial market size is studied on the basis ofproduct type, livestock, and region. By product type, the market is bifurcated into lactic acid bacteria, bacillus, and other organisms. Dependingon livestock, the market is classified into swine, poultry, ruminants, aquatic animals, and other livestock animals. Region wise, itisanalyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
By product, the lactobacillus segment accounted for more than half the share of total market in 2018, and is expected to exhibit a prominent growth rate in the near future, owing to its increased usage in the livestock diet. Furthermore, Lactobacillus species is the most widely used probiotics in the livestock diet, as it is considered safe and more beneficial as compared to the other bacterial species.In addition, the other benefits offered by the bacillusdirect fed microbial include improved normal digestion, and improved nutritional value of the feed as Bacillus strains produce vitamins and essential amino acids. Furthermore, other benefits include reduction in hepatic total cholesterol, plasma low-density lipoprotein cholesterol, and triglycerides, which promote better health in animals. Thus, all these factors are anticipated to fuel the direct fed microbial market growth in near future.
Lactic Acid Bacteria is projected as one of the most lucrative segment.
By livestock, the poultry segment acquired the major direct fed microbial market size in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that poultry is the most consumed animal meat across the globe. Furthermore, individuals prefer poultry other than other livestock animals, which boosts the market growth.
Poultry holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
By region, North America accounted for the major direct fed microbial market share in 2018, and is expected tocontinue this trend,owing to easy availability of direct fed microbial products. Moreover, surge in the demand for probiotics and rise in awareness toward maintenance of healthy lifestyle in the region are the major reason that contribute to the growth of this market. However, Asia-Pacific is expectedto register the fastest growth during the forecast period attributedto increasein awareness regarding the use of direct-fed microbial.
Asia-Pacific region would exhibit the highest CAGR of 8.5% during 2019-2026.
The global direct fed microbial market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Koninklijke DSM N. V, Bio-Vet, Archer-Daniels-Midland Company, CHR. Hansen A/S, E. I. Du Pont De Nemours And Company, Novozymes A/S, Kemin Industries, Inc., BASF SE (BASF Corporation), Evonik Industries Ag, and Adisseo.
Key Benefits For Stakeholders
This report entails a detailed quantitative analysis along with the current global direct fed microbial market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
The direct fed microbial market forecast is studied from 2019 to 2026.
The direct fed microbial market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the direct fed microbial market
Key Market Segments
By Product Type
- Lactic Acid Bacteria
- Aquatic Animals
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Direct Fed Microbial Market Report Highlights
By Product Type
Key Market Players
CHR. HANSEN A/S, KEMIN INDUSTRIES, INC., ARCHER-DANIELS-MIDLAND COMPANY, BIO-VET, Novozymes A/S, EVONIK INDUSTRIES AG, ADISSEO, KONINKLIJKE DSM N. V., E. I. DU PONT DE NEMOURS AND COMPANY, BASF SE (BASF Corporation)
The administration of probiotics helps to increase the animal feed efficiency and improves the balance of gut microflora. These probiotic microbial strains help to break down the complex substances consumed by the animal, converting them into simple compounds. These simple compounds can easily be used for energy conversion by the animals thereby improving the nutrient absorption in the animals. This helps to increase the production of meat and milk in ruminant animals, which, in turn, benefits animal producers. Moreover, probiotic microbes help to modulate the immune response in animals. This helps to reduce the probability of animals being affected by different diseases, increasing their mortality rate and improving the quality of animals produced. Although the cost of direct-fed microbial products are high, the use of these products are cost-effective for the animal producers.